One of the most promising task is the ability to engineer nanocarriers that can autonomously navigate within tissues and organs, accessing nearly every site of the human body guided by endogenous chemical gradients.
Introduction
Directional locomotion or taxis is possibly one of the most important evolutionary milestones, as it has enabled many living organisms to outperform their non-motile competitors. In particular, chemotaxis (i.e. the movement of organisms either toward or away from specific chemicals) [6, 7] is possibly the most common strategy adopted by many unicellular organisms to gather nutrients, escape toxins [8] and help coordinate collective behaviours such as the formation of colonies and biofilms [9] . Chemotaxis is also exploited by multicellular systems for tissue development [10] , immune responses [11] or cancer metastasis [12] . It enables long-range interactions that extend over length scales that are several orders of magnitude larger than the motile system itself [13] . It is not surprising that scientists have been trying to design devices that mimic such a behaviour [1, 2, 3, 4] . When swimming is scaled down to the microscale, the fluid dynamics are dominated by viscous rather than inertial forces (i.e. Stokes regime). In such conditions, propulsion is possible only by not-time-reversible deformations of the swimmer's body [14, 15] or by inducing a phoretic slip velocity on the swimmer's surface [16, 17] . The latter can, for example, be achieved by creating thermal gradients (thermophoresis) or chemical gradients of either charged (electrophoresis) or neutral (diffusiophoresis) solutes in the swimmer's environment [16] . Recently it has in fact been proposed that the swimmer can induce a slip velocity on its surface by generating an asymmetric distribution of reaction products that creates a localised chemical gradient. This concept known as self-diffusiophoresis was formalised theoretically [18] and demonstrated experimentally using latex particles [19] and gold/silver rods [20] . From a biotechnological point of view, self-propulsion can be applied to create carriers able to autonomously navigate within biological fluids and environments. This could enable directed access to nearly every site of the human body through blood vessels, independent of the blood flow and local tissue architectures. To this respect, recent preliminary experiments were performed with inorganic micro-particles propelled by pH in the stomach of living mice [21] . The ability to control active diffusion as a function of a physiological stimulus bodes well for tackling challenges in drug delivery where an efficient approach is yet to be found. Among these, the ability to deliver drugs within the central nervous systems (CNS) is one of the most difficult tasks where current approaches only enable small percentage of the injected dose to reach the brain and the spinal cord [22, 23] . The brain and the rest of the CNS are well guarded by physiological barriers, with the blood brain barrier (BBB) being the most important. The BBB has the dual function to protect the CNS and to ensure it receives an enhanced supply of metabolites. The brain is indeed the most expensive organ in our body [24] consuming almost 20% of oxygen and glucose. The latter is possibly one of the most important CNS nutrient [25] and the BBB regulates its passage very e ectively, with a consequent natural glucose gradient from the blood to the brain.
Here we propose the design of an autonomous nanoscopic swimmer based on the combination of naturally occurring enzymes with fully biocompatible carriers, known as polymersomes, that have already proven to hold great promise as drug and gene delivery vehicles [26, 27] . Speci cally, in order to target the BBB and enter the CNS [28] , we equip polymersomes with the ability to self-propel in the presence of glucose concentration.
Results and discussion
Asymmetric polymersomes. Polymersomes are vesicles formed by the self-assembly of amphiphilic copolymers in water [29] . They have been proposed as an alternative to liposomes (vesicles formed by naturally occurring phospholipids) as they o er greater exibility over chemical and physical properties, and allow large amounts of biological molecules, including proteins and nucleic acids, to be compartmentalised into nanoscale reactors [30, 31] . Furthermore, we have demonstrated [32, 33, 34, 35] that, when two di erent copolymers are used to form one polymersome, the resulting membrane segregates laterally into patterns whose topology is strictly controlled by the molar ratio of the two copolymers and eventually coarsen into two separate domains forming asymmetric polymersomes [36] . In this article, we exploit this asymmetry to achieve propulsion at the nanoscale. We mixed either poly((2-methacryloyl) ethyl phosphorylcholine)-PDPA (PMPC-PDPA) or poly[ oligo(ethylene glycol) methyl methacrylate]-poly(2-(diisopropylamino)ethyl methacrylate) (POEGMA-PDPA) with poly(ethylene oxide)-poly(butylene oxide) (PEO-PBO) copolymers. PMPC-PDPA and POEGMA-PDPA have been established in vivo for targeting cancer cells [37, 38] and, most relevantly here, for crossing the BBB and entering the CNS when combined with the LRP-1 targeting peptide Angiopep-2 (LA) [28] . PEO-PBO forms very thin membranes ( 2.5 nm) [39] that are highly permeable to most small polar molecules, such as hydrogen peroxide and glucose [40] . The schematics of our proposed design is shown in Fig. 1a . The two copolymers form asymmetric polymersomes at a 9:1 molar ratio with the small permeable bud being formed by the minor PEO-PBO component. This can be veri ed using transmission electron microscopy (TEM) by imaging the polymersomes using positive staining selective for the PDPA blocks (see Figs. 1b-c for the PMPC-PDPA/PEO-PBO and the PEOEGMA-PDPA/PEO-PBO mixtures respectively). As shown using negative staining TEM (Fig. 1d) where the PBO domain is darker, the thickness of the two membranes can be measured to be about 6 nm and 2.4 nm confirming previously reported measurements [26, 39] . We can employ such an asymmetric polymersome to encapsulate enzymes using a technique based on electroporation [31] . We chose glucose oxidase to catalyse the glucose oxidation to form d-glucono-δ-lactone and hydrogen peroxide and catalase to catalyse the decomposition of hydrogen peroxide into water and oxygen. Both enzymes and reagents are naturally occurring in the human body. As shown in Supplementary Table 1 and Supplementary Fig. 1 , we encapsulated an average of 6 glucose oxidases and 2 catalases per polymersome either alone or in combination. We thus hypothesise that, as the enzymes react with their respective substrates, the confined reactions will produce a flux of products that will be preferentially expelled out of the polymersomes from the most permeable patch, i.e. the bud formed by the minor PEO-PBO component. This in turn generates a localised gradient of the products that should set up the conditions for self-propulsion. The nature of the propulsion mechanism depends on the interaction between the reaction products and the two different polymersome domains [16] . To a first approximation, this should set the conditions for self-diffusiophoresis where the depletion of the product molecules near the polymersome surface induces a lateral water flow with slip velocity, v S . Assuming a spherical geometry of radius R, the polymersome propulsion translation and angular velocity can be derived form the slip velocity
(v S × n) dA respectively, with A being the total polymersome surface area and n the polymersome orientation unit vector. This vector originates from the polymersome centre of mass and its directed toward the centre of the asymmetric PEO-PBO domain. Both velocities can be used to derive the general equations of motion expressed as a function of the polymersome position r and orientation unit vector n as:
where k is the Boltzmann's constant, T the absolute temperature, η the water viscosity, W t and W r are white noise vectors that respectively model the translational and rotational Brownian diffusion of the particle [5, 16] .
Active diffusion analysis. To characterise the motility of the polymersomes, we have employed a technique known as nanoparticle tracking analysis (NTA) [41] . This is based on the dark-field parallel tracking of thousands of single nanoparticles using a camera to detect the light of a monochromatic laser scattered by the particles. The geometry of the observation chamber is shown in Supplementary Fig. 2 and, unless specified differently, we performed all the measurements at physiological conditions, i.e. T = 37
• C, η water = 0.69 mPas in 100 mM phosphate buffer solution (PBS). The trajectories and the corresponding mean square displacements (MSDs) can be used to evaluate the motility of the polymersomes. In Supplementary Figs. 3-13 we show 1-s trajectories (all normalised to a common origin) and the corresponding MSDs for thousands of polymersomes imaged at 30 frames per second (fps) under different environmental conditions. In a homogeneous environment, either in presence or absence of the substrate, the results show that, independently of being symmetric or asymmetric, loaded with enzymes or empty, the polymersomes have a typical Fickian diffusion profile with linear MSDs and stochastic trajectories. While the MSDs averaged over thousands of trajectories ( Supplementary Figs. 3-5) show some variations in the long-time diffusion coefficient, these variations are mainly due to statistical fluctuations between different experimental realisations of the process. In particular, we do not observe any appreciable enhancement in diffusivity. This suggests that even if the enzymatic reaction creates an asymmetric distribution of products around the loaded patchy polymersomes, with consequent propulsion velocity, any corresponding directed part of the motion is not sufficient to overcome the polymersome high rotational diffusion due to its small size (z-average measured by DLS R = 50 ± 10 nm, Supplementary Fig. 1 ), which effectively hinders any self-propulsion by effectively randomising the particles' orientations in τ ≈ 0.5 ms, one order of magnitude below our experimental time resolution (about 33.3 ms). To further confirm this, we calculated the ratio between the theoretical enhanced diffusion coefficient D ef f and the Stokes-Einstein diffusion coefficient D 0 ( Supplementary  Fig. 14 ) [19] : these calculations confirm that any enhancement in diffusion is small for realistic values of size and velocity in our system (D ef f /D 0 < 1.2), thus making it difficult to detect given the experimental variability. Furthermore, both experiments and calculations suggest that the angular phoretic term proportional to Ω in equation 2 is considerable smaller than the Brownian rotational component and hence can be ignored hereafter. We repeated the same set of experiments of Supplementary Figs. 3-5 in the presence of a concentration gradient created by adding the substrate from one side of the observation chamber ( Fig. 2 and Supplementary Figs.  6-13 ). Under the new experimental conditions, the symmetric polymersomes (either loaded or empty) as well as the empty asymmetric polymersomes still showed a typical Fickian diffusion profile with stochastic trajectories and linear MSDs as a function of time. As a reference, Fig. 2a only shows the data corresponding to the case of symmetric polymersomes loaded with both glucose oxidase and catalase responding to a gradient of glucose (generated by a 1M-solution at the injection site), while the other control measurements are reported in Supplementary Figs . 6-9. The enzyme-loaded asymmetric polymersomes instead responded quite differently to the gradient of their respective substrate (Figs. 2b-e). Fig. 2b shows the data for the asymmetric polymersomes loaded with catalase alone (Cat) responding to a hydrogen peroxide gradient (generated by a 1mM-solution) coming from the right-hand side of the observation chamber; the normalised trajectories are biased toward the gradient and the corresponding MSDs show a ballistic behaviour with a quadratic dependence on time. Such a super-diffusive behaviour is considerably more pronounced for the asymmetric polymersomes loaded either with glucose oxidase alone (Gox) (Fig. 2c) or glucose oxidase and catalase (Gox+Cat) together ( Fig. 2d-e) responding to a glucose gradient generated by a 1M solution; almost all the trajectories are aligned toward the gradient, whether this comes from the right- (Fig. 2d) or the left-hand side (Fig. 2e) . In addition to the trajectory and MSD analysis, the average drift velocities are plotted in Fig. 2f as a function of the time of observation after the substrate addition. For Brownian particles such as those in the control samples, the average drift velocity is zero but, as the samples become more chemotactic, the drift velocity gradually increases. The variation of the drift velocity as a function of time after the addition of the substrate allows us to estimate how the self-propulsion behaviour varies with the chemical gradient magnitude, and, in all cases the drift velocity equilibrates to a plateau value corresponding to the time when the gradient becomes linear (i.e. ∇C ≈ constant) and system reaches steady-state conditions. Finally, the distribution of the particle orientation with respect to the direction of the substrate gradient is plotted in Fig. 2g for all cases. Brownian samples (such as all the controls) have directions almost equally distributed across all angles, while, as the sample starts to exhibit propulsion and chemotaxis, the distribution of particles polarises toward the direction of the gradient. All the data displayed in Fig. 2 show that independently of the enzyme/substrate system, asymmetric polymersomes show typical ballistic behaviour with a chemotactic response towards the enzyme substrate gradient marked here as θ = 0. The catalase-loaded polymersomes respond rather weakly to the hydrogen peroxide gradient and this is independent of the peroxide initial concentration. Glucose oxidase-loaded asymmetric polymersomes, on the other hand, respond very strongly to a glucose gradient, reaching drift velocities around 20 µm s −1 with most particles polarised toward the gradient. Interestingly, similar values are comparable to those of chemotactic bacteria, such as E. coli, which are one order of magnitude larger than the polymersomes studied herein [9] . As shown in Fig. 1a , glucose oxidase and catalase operate very well together as their respective reactions feed each other with hydrogen peroxide being a product of glucose dissociation and the oxygen being a product of hydrogen peroxide dissociation. Furthermore, their combination leads to the formation of non-detrimental molecules as both oxygen and hydrogen peroxide are consumed and transformed into water and d-glucono-δ-lactone. Most notably, glucose oxidase and catalase loaded asymmetric polymersomes had the strongest response to glucose gradients, and indeed produced slightly higher drift velocities and considerably more polarised chemotaxis than the system loaded with glucose oxidase alone or catalase alone. From these data we can conclude that: (i ) the asymmetric distribution is critical, indeed symmetric polymersomes (either made of PDPA or PBO membranes) loaded with enzymes did not show any chemotactic drift; (ii ) the reaction is critical, and empty polymersomes either symmetric or asymmetric do not exhibit any diffusophoretic drift due only to the substrate gradient; and finally (iii ) only when the enzymes are encapsulated within an asymmetric polymersome chemotaxis is exhibited suggesting that the propulsion velocity is only proportional to the products ∇C p . These conclusions suggest that, in the presence of a gradient, the strength of the polymersomes' propulsion velocity is strongly biased by its orientation so to create an asymmetric angular probability in the particle's motion that is higher when the particle is oriented toward the gradient. Assuming a spherical polymersome with R = 50 nm and a smaller semi-spherical bud stemming from it with radius, r = 15, we can estimate such an angular probability by representing the asymmetric polymersome in a coordinate system where the substrate gradient has only one component along the x-axis (Fig. 3a) . Using such a simplified geometry, we can simulate the distribution of the products' concentration just outside the PBO permeable patch at different orientations θ (Supplementary Note 3.4.2). As plotted in Fig. 3a , this is extremely biased toward the substrate gradient and can be approximated with the function ∆C p = A cos(
2n , where A is a proportionality constant and π n is the sector angle of the PBO domain. Since the gradient in the product distribution around the particle is in first approximation proportional to such ∆C p [18, 19] , the propulsion velocity can be estimated from the data by describing its functional form with the same modulation in the vesicle's orientation. In fact, such an approximation, together with the assumption that the polymersome's phoretic angular velocity Ω is negligible when compared to its rotational diffusion, allow us to simulate the propulsion of the polymersomes in the presence of the substrate gradient by using equations 1 and 2 (Supplementary Note 3.3). As shown in Fig. 3b , the simulations (solid lines) fit the experimental data (circles) and they allow us to estimate the strength of the propulsion velocity for each formulation (Fig. 3c) . Once again the (Gox + Cat) formulation is the one with the highest propulsion velocity and the formulation with catalase alone in the presence of hydrogen peroxide the one with the lowest value. Moreover, the simulations also allow us to access the dynamics of propulsion with no limits in both spatial and temporal resolution. In Fig. 3d we show the simulated trajectories normalised to a common origin not peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprint (which was . http://dx.doi.org of 20 polymersomes with a temporal sampling identical to our experimental setting (i.e. 0.033 s corresponding to a 30 fps acquisition rate). As we zoom in and increase the temporal resolution up to 0.033 ms (corresponding to a 3 10 5 fps acquisition rate), the polymersome trajectories reveal that they are the result of a succession of running and tumbling events within the ms timescale and hence the vesicles quickly re-orient toward the gradient with consequent self-propulsion.
Chemotaxis in complex environments. In order to get further insight into the chemotactic response of our system, we performed further experiments on the polymersomes loaded with both enzymes to assess their chemotactic capability more quantitatively using the approach shown in Fig. 4a . A cylindrical agarose gel, presoaked in a 1-M glucose solution, was placed on the edge of a Petri dish lled with PBS. Various polymersome formulations were added at the centre of the dish with a syringe pump. Samples were collected at di erent locations within the Petri dish and at di erent time points as shown in Fig. 4b , and quanti ed for concentration and sizing (Supplementary Note 3.2.1 and Supplementary Figure 15) . In Fig. 4c -e we show concentration maps of the polymersomes in the dish at time 0 (Fig. 4c) and 10 min after their addition, both for the symmetric formulation (Fig. 4d) and for the asymmetric formulation (Fig. 4e) loaded with glucose oxidase and catalase, in response to a glucose gradient. We also studied a di erent con guration (Supplementary Note 3.2.2): a Petri dish pre-lled with uorescent polymersomes where a drop of 1M-glucose solution is added in the centre of the dish, which is directly imaged with a uorescence camera (Fig. 4f ) . The corresponding uorescence images of both symmetric and asymmetric polymersomes before glucose addition and at times t = 0, 10 and 15 min are shown. While the rst experiment shows that the asymmetric polymersomes do not dilute in the presence of the glucose gradient, and instead almost entirely drift towards the glucose source (Fig. 4e) , in the second experiment we can observe that the asymmetric polymersomes can concentrate towards the glucose gradient from high dilutions (Fig. 4g) . These experiments show quite convincingly that the chemotactic polymersomes follow shallow gradients and concentrate towards a given chemical source over time scales of minutes and length scales 10 7 times longer than the swimmer s characteristic size. All the data bode well for bestowing polymersomes with chemotactic capability and indeed augmenting 6 not peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprint (which was . http://dx.doi.org/10.1101/061325 doi: bioRxiv preprint first posted online Jun. 29, 2016; their efficiency in navigating across biological barriers. To understand the effect of flow, we performed the same experiments as in Fig. 2 but in the presence of a constant flow almost perpendicular to the glucose gradient. The two chosen flow rates of 0.5 and 3.5 µlmin −1 , corresponding to velocities of 10 and 150 µms −1 (i.e. Péclet number of 0.15 and 2.3 respectively) represent conditions encountered next to the capillary barriers or right in the capillary centre respectively. As shown in Fig. 5a , the normalised trajectories for both pre-substrate addition and symmetric polymersomes show a typical Gaussian distribution that is more skewed as the flow rate increases from 0 to 3.5 µlmin −1 . At zero flow, the glucose oxidase and catalase loaded polymersomes show a rapid response to the glucose gradient with overall drift plateauing at about 20 min after the addition of glucose. At a flow rate of 0.5 µlmin −1 , the chemotactic drift is still sufficient large to overcome the convection and indeed polymersomes still move toward the glucose gradient, albeit at lower velocities. At a flow rate of 3.5 µlmin −1 , the chemotactic drift combines with the flow inducing a drift of the polymersomes with trajectories taking a direction of about 45
• from the flow line. It is important to note (as shown in Fig. 5a ) that as the flow increases the gradient vector rotates from its original unbiased position to being almost perpendicular to the flow. In order to test the effect of placing chemotactic polymersomes in blood flow, we employed an agent-based model of the nanoparticles in capillaries in the presence of erythrocytes (also known as red blood cells) that we have developed previously [42] . In Fig. 5b , we show a snapshot of the streamlines of the flow observed in a capillary with a radius of 4 µm and length of 800 µm calculated by computational fluid dynamics (Supplementary Note 3.1) . The red cylinders represent erythrocytes (at physiological haematocrit H% =10.7%) and the colour maps show the normal velocity, i.e. the velocity component perpendicular to the vessel wall. We used this geometry and we seeded 100 nanoparticles randomly at the entrance of the vessel and allowed their passage through the vessel. The vessel walls were set as no-slip, sticky boundaries (i.e. as a polymersome approaches the barrier it binds to it), so that the number of nanoparticles bound to the vessel wall could be evaluated with different sized particles and velocities of propulsion. As discussed above, we can assume that as asymmetric polymersomes encounter a glucose gradient they will propel with a propulsion velocity that is directly proportional to the gradient, and their rotation is uniquely controlled by Brownian dynamics. Assuming a glucose gradient across the vessel, we performed the calculations for polymersomes with radius R = 50, 100, and 250 nm, which is representative of a typical size distribution of polymersomes (see DLS measured distributions in Supplementary Fig. 1 ), and to represent the spread of propulsion velocities (see both Figs. 2 and 3) we propelled the polymersomes at 0, 10, 20, 50 and 100 µms −1 . Fig. 5c shows the percentage of particles that bind to the vessel wall during a single passage. Binding to the vessel walls is generally improved by increasing the propulsion velocity. Indeed propulsion augments binding 2-fold from 0 to 100 µms −1 for small nanoparticles and the binding to the wall is considerably improved for the case of larger polymersomes and high propulsion velocity reaching almost 100% of particles binding. Modelling would suggest that adding an element of propulsion to the motion of the polymersomes increases the overall uptake from the blood due to their improved distribution to the endothelial wall interface. Furthermore, the use of glucose as a substrate ensures that there is a high level of substrate available within the blood, as blood glucose is maintained at 4-7.8 mM [25] . In addition, brain metabolism requires high levels of glucose and glucose transporters are well known to be over-expressed on the BBB [25] and hence it is not far-fetched to assume that blood glucose has a positive gradient toward the blood wall and an even more favourable distribution within the brain. Recently, we have demonstrated that polymersomes can be conjugated with peptides that target the LRP-1 receptor. This receptor is over-expressed at the BBB and it is associated with a transport mechanism known as transcytosis. We have demonstrated that by targeting this pathway we can deliver large macromolecules to CNS resident cells [28] . We have here used this system to demonstrate that chemotaxis can indeed augment delivery significantly. This effect was validated in the rat CNS through in situ perfusion. Chemotactic polymersomes, responsive to glucose and functionalised with LA, demonstrated about a 4-fold delivery increase into the parenchyma compared to non-chemotactic polymersome controls (Fig. 5d) . The non-active polymersomes were optimised to reach a respectable 5% of the injected dose. However, modifying the polymersomes, by adding an asymmetric patch and by loading them with glucose oxidase and catalase, enabled a staggering delivery of 20% of the injected dose, which to the best of our knowledge has never been reported so far with any other system.
Conclusions
We have shown here that an established intracellular delivery system such as PMPC-PDPA and POEGMA-PDPA polymersomes can be modified to possess chemotactic capabilities toward glucose gradients. We achieve this by using a novel process of converting a chemical potential difference into an actual propulsion mechanism capable of tracking small molecule gradients over distances that are many orders of magnitude greater than the nanoparticle's characteristic length. We have shown that this approach is very flexible and chemotaxis can be achieved, albeit with variable efficiencies, using different combinations of enzyme and substrate as demonstrated with catalase with hydrogen peroxide and glucose oxidase with glucose. Moreover we have shown that the combination of glucose oxidase and catalase makes a very efficient chemotactic polymersome in the
presence of a glucose gradient. Glucose oxidase and catalase work in tandem to create propulsion, transforming endogenous occurring glucose to endogenous occurring d-glucono-δ-lactone and water, without the formation of potentially harmful compounds such as hydrogen peroxide and gaseous oxygen. Most importantly we have shown that chemotaxis can make a tremendous difference in augmenting delivery across the blood brain barrier, where we have demonstrated an increase of almost 4-fold in the amount of polymersomes gaining access to the brain parenchyma of rats compared to BBB-targeting, non-chemotactic polymersomes. This is a strong finding that we envision will set a completely new trend in the design of drug delivery systems embracing the new advances being proposed in active colloids.
Methods
Materials. Chemicals were used as received unless otherwise indicated. 2-(Methacryloyloxy)ethyl phosphorylcholine (MPC > 99%) was kindly donated by Biocompatibles, UK. 2-(Diisopropylamino)ethyl methacrylate (DPA) was purchased from Scientific Polymer Products (USA). Copper(I) bromide (CuBr; 99.999%), 2,2-bipyridine (bpy), methanol (anhydrous, 99.8%) and isopropanol were purchased from Sigma Aldrich. The silica used for removal of the ATRP copper catalyst was column chromatography grade silica gel 60 (0.063-0.200 mm) purchased from E. Merck (Darmstadt, Germany). 2-(N-Morpholino)ethyl 2-bromo-2-methylpropanoate (MEBr) initiator was synthesised according to a previously reported procedure [43] . Poly (ethylene glycol) methyl ether methacrylate P(OEG10MA) was purchased from Sigma Aldrich UK (Dorset, UK). PEO-PBO copolymer was purchased from Advanced Polymer Materials Inc. The polymersomes were labeled using Rhodamine B octadecyl ester perchlorate purchased by Sigma-Aldrich. PBS was made from Oxoid tablets (one tablet per 100 ml of water). Bovine liver Catalase, Glucose Oxidase and glucose have been purchased from Sigma-Aldrich. The gel filtration column for the purification of the polymersomes was made with Sepharose 4B, purchased from Sigma-Aldrich.
PMPC 25 -PDPA 70 copolymer synthesis. The PMPC-b-PDPA diblock copolymer was prepared by ATRP [43] . In a typical ATRP procedure, a Schlenk flask with a magnetic stir bar and a rubber septum was charged with MPC (1. 6 mmol) and methanol (7 ml) mixture were injected into the flask. After 48 h, the reaction solution was diluted by addition of ethanol (about 200 ml) and then passed through a silica column to remove the copper catalyst. The reaction mixture was dialysed against water to remove the organic solvent and then freeze dried. Finally, the copolymer molecular weight was checked by NMR analysis. P(OEG 10 MA) 20 -PDPA 100 copolymer synthesis. The protected maleimide initiator (Mal-Br) was prepared according to a previously published procedure [44] In a typical procedure, either ME-Br or Mal-Br initiators ATRP initiators (0.105 mmol, 1 eq) was mixed with OEG 10 MA (1 g, 2.11 mmol, 20 eq). When homogeneous, 1 ml water was added, and the solution was purged with nitrogen for 40 minutes. Then, a mixture of CuCl (10.4 mg, 0.105 mmol) and bpy (32.9 mg, 0.210 mmol) was mixed. After 8 minutes, a sample was removed and a nitrogen-purged mixture of DPA (2.2455 g, 0.0105 mol, 100 eq) mixed with 3 ml isopropanol was added to the viscous mixture via cannula. After 18 h, the mixture was diluted with methanol. Then, 2 volumes of dichloromethane were added. The solution was passed through a column of silica using dichloromethane : methanol 2 : 1 to remove the copper catalyst. The resulting solution was dialysed (MWCO 1,000 Da) against ethanol and water and freeze-dried. The resulting copolymer composition was determined by NMR analysis.
Copolymer conjugation with cysteine-terminated peptide The deprotected Mal-P(OEG 10 MA) 20 -PDPA 100 (105.6 mg, 3.4 µmol maleimide) was dispersed in 4.5 ml nitrogen-purged PBS at pH 7.3. The pH was lowered by addition of concentrated HCl (10 µl) to give a uniform solution. The pH was then increased to 7.8 with 5 M NaOH and the resulting opaque dispersion was sonicated for 10 min. 2.3 ml of this solution was transferred to a second flask. Both solutions were then purged with nitrogen for 10 minutes. (This should give an approximate maleimide amount in each flask of 1.7 µmol). To the original solution was then added Cys-Angiopep (5.5 mg, 2.3 µmol thiol) followed by TCEP (2 mg, 7 µmol). The pH in each solution was measured to 7. Both solutions were left for 17 h. Then, both solutions were dialysed against water (MWCO 8,000) to remove any excess peptide, followed by freeze-drying. Successful labelling was confirmed using a HPLC with fluorescence and absorption detection: contains fluorescent tyrosine residues, rendering the polymer-peptide conjugates fluorescent at 303 nm when excited at 274 nm. On the other hand, the non-labelled polymer does not exhibit any fluorescence at these wave-lengths (but can be detected using the absorption detector).
Polymersome Preparation. Nanometer-sized polymersomes were formed by the film rehydration method [45, 46] . The block copolymers were dissolved in 2:1 v/v chloroform/methanol at 10 mgml −1 total copolymer concentration in the organic solvent. Asymmetric polymersomes were obtained by dissolving premixed copolymers at 90% PMPC 25 -PDPA 70 or P(OEG 10 )MA 20 -PDPA 100 and 10% PEO 16 -PBO 22 in molar ratio. Rhodamine B in chloroform solution was added to the above solutions to create a 50 µgml −1 fluorophore final concentration. Polymeric films were obtained by drying the copolymer solutions in vacuum oven overnight. In a typical experiment, PBS 0.1 M (pH 7.4) was added to the polymeric films and they were let stir for 30 days at room temperature to obtain the formation of PEO-PBO domains on the PMPC-PDPA polymersomes surface. Topological asymmetry and size distribution have been characterise by TEM and DLS analysis respectively.
Transmission electron microscopy(TEM). A phosphotungstenic acid (PTA) solution was used as positive and negative staining agent because of its preferential interaction with the ester groups on the PMPC polymers [47] , which are not present in the PEO-PBO copolymer. The PTA staining solution was prepared dissolving 37.5 mg of PTA in boiling distilled water (5 ml). The pH was adjusted to 7.4 by adding a few drops of 5 M NaOH with continuous stirring. The PTA solution was then filtered through a 0.2 µm filter. Then 5 µl of polymersome/PBS dispersion was deposited onto glow-discharged copper grids. After 1 min, the grids were blotted with filter paper and then immersed into the PTA staining solution for 5 s for positive staining, 10 s for negative staining. Then the grids were blotted again and dried under vacuum for 1 min. Grids were imaged using a FEI Tecnai G2 Spirit TEM microscope at 80 kV.
Dynamic light scattering (DLS).
The sample was crossed by a 120 mW He-Ne laser at 630 nm, at a controlled temperature of 25®and the scattered light was measured at an angle of 173°. For the analysis, the sample was diluted with filtered PBS pH 7 at a final concentration of 0.2 mgml −1 into a final volume of 500 µl and finally, analysed into a polystyrene cuvette (Malvern, DTS0012). All DLS data were processed using a Dispersion Technology Software (Malvern Instruments).
Reversed phase high pressure liquid chromatography (RP-HPLC). RP-HPLC was performed with Dionex Ultimate 3000 instrument equipped with Variable Wavelength Detector (VWD) to analyse the UV absorption of the polymers at 220 nm and the enzymes signal at 280 nm. A gradient of H 2 O+Tryfluoroacetic acid 0.05% (TFA) (A) and MeOH+TFA 0.05% (B) from 0 min (5%B) to 30 min (100%B) was used to run the samples trough a C18 column (Phenomenex). The peak area was integrated by using Chomeleon version 6.8.
Enzymes encapsulation Electroporation was used to allow the entrapment of glucose oxidase, catalase or the combination of the two within the polymersomes. The optimal setting used for the electroporation was 10 pulses at 2500 V [48] . After electroporation, the samples were purified by preparative gel permeation chromatography. Then, the amount of polymer and encapsulated enzymes were quantified by reversed phase high pressure liquid chromatography.
Encapsulation efficiency calculation. HPLC and DLS data were combined to calculate the number of polymersomes produced in any experiment. The encapsulation efficiency was defined as the number of molecules of enzyme loaded in each polymersomes. The number of polymersomes in a sample can be estimated from the aggregation number (N agg ), defined as:
where R is the particle radius from the DLS, l b is the length of the hydrophilic PMPC brush, t m is the thickness of the PDPA membrane and v P DP A is the molecular volume of a single PDPA chain. The number of polymersomes (N ps ) in the sample is defined as
where [P ] is the moles of copolymer in the sample, N a is Avogadro's number and Φ i R i is the fraction of sample at a defined radius R. Finally, the encapsulation efficiency, e, is given by:
where N e is the number of enzymes in the sample. The average of encapsulated enzymes per polymersome were 1.9 ± 0.25 for the Catalase and 6 ± 0.45 for the Glucose Oxidase. Results are shown in Supplementary Table  1 and in Supplementary Fig. 1 .
NTA measurements of polymersomes diffusion. Nanoparticle Tracking Analysis (NTA) was performed with a Nanosight ® LM14 instrument equipped with a Scientific CMOS camera mounted on an optical microscope to track scattered light by particles illuminated a focused (80 µm) beam generated by a single mode laser diode (405 nm). The polymersomes solution (1 ml) was injected in a concentration of approximately 100 particles/ml in PBS. Samples and controls were injected into the Nanosight ® chamber as described in the Supplementary  Fig. 2 . Two different population of polymersomes (asymmetric and symmetric) were analysed with hydrogen peroxide/glucose, depending on the loaded enzyme. Particles were tracked by the built-in software for 60 seconds at 30 fps. The recorded tracks were analysed using Matlab ® . Origin of movement for all particles was normalised to Cartesian coordinates (0,0). The mean square displacement (MSD) of all particles was calculated as reported in [49] . Tracks were analysed for 1 s. Particles not tracked for at least 1s were discarded from the analysis. The average number of tracks per sample ranged from 2000 to 10000 traces.
Brain in situ perfusion. All animal experiments were performed in accordance with the Animals (Scientific Procedures) Act 1986 (U.K.) Male adult Wistar rats were anaesthetised with 100 mgkg −1 ketamine and 1 mgml −1 medetomidine via intraperitoneal injection. The right and left external carotid arteries were isolated from the carotid sheaths and cannulated according to a previously established procedure [50] . The perfusion fluid was modified Ringer's solution (6. , with a total perfusion rate of 1.5 mlmin −1 and a total perfusion time of 10 min. At the end of the perfusion time, the syringe pump was stopped and the arteries were flushed for 60 s with modified Ringer's perfusate in order to remove unbound polymersomes. After 60 s, cerebrospinal fluid was extracted via cisternal puncture followed by decapitation and removal of the brain.
Quantification of polymersome distribution in the rat brain. After decapitation, brains were removed and washed in ice cold 9 gL −1 , followed immediately by homogenisation on ice to initiate the capillary depletion method [50] . Briefly, the cerebellum was removed and the cerebrum was weighed, adding 2x brain weight in PBS followed by 3x dilution in 30% (w/v) dextran (average MW 64-74 kDa). Centrifugation of homogenates at 7400g for 20 minutes in 4°C resulted in several fractions that were carefully separated: capillary depleted (CD) fraction (i.e. parenchyma), dextran, and the capillary enriched fraction (pellet). The capillary enriched pellet was re-suspended in PBS, and 100 µ L samples were added to a black 96-wellplate and read in a fluorimeter at an excitation wavelength of 540 nm and emission at 565 nm. All sample fluorescence readings were normalised to readings obtained from sham perfused rats (n=3) for each sample type, i.e. CD, dextran or capillaries. Positive controls were polymersomes in perfusate harvested from the cannula at the injection point. Normalised fluorescence readings were converted to polymersome (Cy3) amount was converted into percentage injected dose %id of the positive control value for that experiment, where %id = [normalised sample value (mg) / mean positive control value (mg)] * 100. This was further converted into fluorescence per whole brain. All statistical analysis was one-way ANOVA, p <0.05.
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